Or a whale / biopharma loading up in an attempt to lower the cost of a buyout offer.

I say offer b/c I would think (hope) it would be rejected

Quote:

---

If I were a Gilead or some other entity threatened by Leronlimab in an open OTC market, I think I would be able to figure out a way to mow the grass on a chart. My organization could sell or short every time CYDY spiked. We could keep the ceiling near the floor with all of our BP funds and our interests at stake.

By doing this, we might reduce investor confidence, drive negative PR and volatility, defend against an up listing to a major index, and increase my own leverage in a buyout proposition.

Read More: https://investorshangout.com/post/newpost/605...z6JTMC82KJ

---